<DOC>
	<DOCNO>NCT00207077</DOCNO>
	<brief_summary>The purpose study find safe effective dose combination cetuximab ( Erbitux ) Tarceva ( erlotinib ) .</brief_summary>
	<brief_title>Study Cetuximab Combination With Tarceva Patients With Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Cetuximab</mesh_term>
	<mesh_term>Erlotinib Hydrochloride</mesh_term>
	<criteria>Measurable disease Life expectancy least 3 month Must least one prior chemotherapy contain platinum Known document brain metastasis Prior cetuximab therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Advanced Solid Tumors</keyword>
</DOC>